Back to search

Aristotle University Of Thessaloniki (AUTH)

Σύγχρονη φαρμακογνωστική μελέτη του ενδημικού είδους Origanum dictamnus L. Έλεγχος ποιότητας των ειδών Salvia rosmarinus (L.) Schleid και Salvia officinalis L.

Abstract

dc:description

The species Origanum dictamnus L., known as "dittany," has been used since antiquity for the treatment of gastrointestinal and gynecological disorders, as well as for wound healing. Today, the plant is registered by the EMA as a Traditional Herbal Medicinal Product and is indicated for the treatment of cough, relief from gastrointestinal disturbances, and wound healing. In Crete, where dittany is an endemic species, it is widely used in the form of infusions and decoctions to address gastrointestinal discomfort, as a topical healing agent, and for dysmenorrhea, holding a unique significance in local tradition. Extensive chromatographic separations were conducted initially to thoroughly investigate the plant's chemical composition. A metabolomic approach was employed, ensuring both the rapid identification of known metabolites (dereplication) and the detection of target natural products and new natural compounds. This was achieved by combining two analytical techniques, NMR and HPLC-PDA-MS, alongside classical TLC, applied at each stage of the process. Chromatographic isolations were performed on the aerial parts and, for the first time, on the roots, while the chromatographic profile of dittany infusion was also studied via HPLC-PDA-MS. A total of 44 compounds were isolated/detected, eight of which were spectroscopically characterized for the first time. The structures were elucidated using 1D- and 2D-NMR spectroscopy and, where necessary, circular dichroism. The compounds described for the first time include I4-II7-di-carvacrol (4) (Paloukopoulou et al., 2022), abietatriene-3β,6β-diol (5), 2′′′-caffeoyl-apigenin-7-O-β-glucuronopyranoside (24), apigenin-7-O-[2′′′-caffeoyl-glucuronopyranosyl-(1→2)]-O-glucuronopyranoside (25), luteolin-7-O-[2′′′-caffeoyl-glucuronopyranosyl-(1→2)]-O-glucuronopyranoside (26), apigenin-7-O-[2′′′-feruloyl-glucuronopyranosyl-(1→2)]-O-glucuronopyranoside (27), luteolin-7-O-[2′′′-feruloyl-glucuronopyranosyl-(1→2)]-O-glucuronopyranoside (28), and the depside dittany acid (37).Subsequently, in vitro studies were conducted to evaluate the antibacterial, antifungal, and anticancer activities of these compounds. The impetus for investigating their antimicrobial properties stemmed from ethnopharmacological references citing the use of the herb for throat pain relief during colds, as well as from literature focusing primarily on essential oils. The antibacterial activity of the compounds was assessed against bacterial strains such as Staphylococcus aureus (methicillin-resistant) and Pseudomonas aeruginosa (carbapenem-resistant). Additionally, since previous studies have shown that phenolic compounds can act as carbonic anhydrase inhibitors, a broader range of phenolic structures from Origanum dictamnus was investigated for their inhibitory effect against the fungal β-MgCA and their antifungal activity against the strain Malassezia globosa. The plant's depsides salvianolic acid P and dittany acid were studied for their inhibition of the cancer-associated human carbonic anhydrase isoforms hCA IX and XII. The compounds demonstrated significant inhibitory activity against hCA IX and effectively inhibited the second isoform hCA XII as well. The binding mode of the ligands to the enzyme was studied using crystallography, which revealed that salvianolic acid P binds by creating multiple stabilizing interactions both within the active site and at the boundaries of the enzyme structure. Finally, the compounds were evaluated for cytotoxicity against a standard human cell line from triple-negative breast cancer (MDA-MB-231) and showed significant cytotoxic activity. Considering the ethnopharmacological use of the plant for gastrointestinal disorders, preliminary experiments were conducted on isolated rabbit intestines, which showed the relaxing effect of dittany infusion. This prompted further investigation into how dittany's constituents are affected by digestive processes during oral administration of the infusion. The following experiments were conducted: (i) ex vivo intestinal permeability evaluation, (ii) in vitro simulated digestion in three phases (oral, gastric, and intestinal), and (iii-iv) stability testing of the infusion in the presence/absence of intestinal tissue. Such data are not included in the official European Community Monograph. The infusion was prepared according to the EMA dosage scheme. The ex vivo permeability experiment was conducted using the non-everted gut sac method on jejunum from rabbit intestines. Each intestinal sac was filled with dittany infusion and placed in glass containers in a water bath at 37 °C. Samples from the perintestinal solution were collected at designated times and analyzed via HPLC-PDA-MS. The in vitro digestion study was conducted in three stages, evaluating enzyme activity: (i) amylase (oral phase), (ii) pepsin in the presence of HCl at pH 2 (gastric phase), (iii) pancreatin and trypsin, as well as bile salts at pH 6.5 (intestinal phase). The permeability test showed that salvianolic acid P derivative 1 exhibited the highest permeability, reaching 12.59 μg/cm². The in vitro digestion study revealed that the infusion's constituents undergo enzymatic breakdown during both gastric and intestinal phases, with the effect being more pronounced in the intestinal phase. Under experimental conditions simulating the intestinal environment (e.g., buffer solution, temperature, and oxygen levels), lignans showed the highest breakdown, reaching 50–60%, while further breakdown was observed for all compounds in the presence of intestinal tissue, with the depside 9 (salvianolic acid P derivative 2) nearing 78%. This degradation trend was common for components containing ester groups. The EMA references to the sedative effect of dittany infusion on the gastrointestinal system and its dual action as both abortive and antispasmodic led to the scientific investigation of these claims. Notably, there are no modern data proving this activity. To address this gap, the pharmacodynamic action of dittany infusion on isolated rabbit intestines was studied. The experiments were conducted on preparations from segments of the small (jejunum) and large intestine (ascending colon). Concurrently, the infusion was quantitatively analyzed using HPLC-PDA-MS to correlate its chemical composition with the pharmacological response. Dittany infusion caused dose-dependent relaxation in rabbit intestines, reducing both the frequency and amplitude of contractions, as well as the basal tone of the ascending colon and jejunum preparations, with the ascending colon being more sensitive. Thus, the ethnopharmacological use of the plant is scientifically confirmed. Additionally, our experiments indicate that non-volatile, water-soluble, phenolic components are responsible for this relaxing effect. Pilot experiments conducted on rabbit intestinal preparations showed that rosmarinic acid, at much lower concentrations compared to those in dittany, had a relaxing effect on both the jejunum and ascending colon. However, the presence of other depsides in significant concentrations in the infusion, as indicated by its percentage composition, suggests that the remaining compounds also warrant pharmacodynamic investigation. Based on the results of dittany's action on the intestine, it was decided to further formulate it into innovative pharmaceutical forms intended for oral administration. The design of films encapsulating dittany infusion was selected. Initially, rosmarinic acid, the infusion's main metabolite, was quantitatively determined and served as a marker for characterizing the preparation. Subsequently, the infusion was formulated with polyvinyl alcohol and chitosan into films via electrospinning. The produced films were characterized for their physicochemical properties, while their infusion content proved satisfactory and industrially viable, ranging from 88.7–90.0% and 82.6–85.8% of rosmarinic acid. Finally, both the films and the infusion showed no cytotoxic action, demonstrating their safe use. In the final part of the doctoral thesis, a methodology was developed for the determination of carnosic acid and carnosol in fresh rosemary and sage leaves using HPLC-PDA. The study was conducted as part of the BIOPHARM program aimed at identifying Greek genotypes producing high amounts of carnosic acid. A rapid RP-HPLC protocol was developed and further optimized, while the methodology was validated for precision and accuracy according to ICH guidelines. The overall method's accuracy (extraction and HPLC) was acceptable, with %RSD values ranging between 1.42 and 4.35. Recovery ranged between 85.1% and 104.6%, with %RSD values <5%, within acceptable limits. The developed methodology was fast and simple, allowing for the rapid and accurate determination of carnosic acid and carnosol in fresh tissues. The methodology was applied to the quantitative analysis of several cultivated samples of S. rosmarinus and S. officinalis, some of which demonstrated good quality as starting materials for developing Greek genotypes rich in carnosic acid.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Paloukopoulou, Charikleia
  • Παλουκοπούλου, Χαρίκλεια

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/58202

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Paloukopoulou, Charikleia; Παλουκοπούλου, Χαρίκλεια. Σύγχρονη φαρμακογνωστική μελέτη του ενδημικού είδους Origanum dictamnus L. Έλεγχος ποιότητας των ειδών Salvia rosmarinus (L.) Schleid και Salvia officinalis L.. Aristotle University Of Thessaloniki (AUTH), 2024. http://hdl.handle.net/10442/hedi/58202